Nektar Therapeutics reported $138.54M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 89.22M 2M
ALKERMES ALKS:US 299.3M 29.33M
Amgen AMGN:US $ 5.7B 1.93B
Astrazeneca AZN:US 7.09B 1.67B
Baxter International BAX:US $ 2674M 118M
Biocryst Pharmaceuticals BCRX:US $ 79.54M 9.1M
Biogen BIIB:US $ 2289.3M 569.2M
Bluebird Bio BLUE:US $ 248.31M 4.31M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Cara Therapeutics CARA:US $ 30.88M 5.38M
Dr.Reddys Laboratories DRRD:IN 44.94B 4.71B
Eisai 4523:JP Y 143487M 10048M
Eli Lilly And LLY:US $ 5336.7M 313.6M
Esperion Therapeutics ESPR:US $ 73.19M 17.61M
Exelixis EXEL:US $ 262.17M 12.67M
Gilead Sciences GILD:US $ 3971M 438M
GlaxoSmithKline GSK:LN 6.42B 692M
Halozyme Therapeutics HALO:US $ 43.41M 15.84M
Immunogen IMGN:US $ 44.32M 305K
IONIS PHARMACEUT IONS:US $ 207.35M 3.77M
Ironwood Pharmaceuticals IRWD:US $ 38.93M 4.51M
Karyopharm Therapeutics KPTI:US $ 71.65M 3.98M
Macrogenics MGNX:US $ 71.04M 2.86M
Merk MRK:US $ 9905M 839M
Mirati Therapeutics MRTX:US $ 164.19M 31.76M
Nektar Therapeutics NKTR:US $ 138.54M 5.5M
Neurocrine Biosciences NBIX:US $ 226.1M 21M
Novartis NOVN:VX 9.82B 464M
Pfizer PFE:US $ 13063M 3998M
Sarepta Therapeutics SRPT:US $ 331.66M 32.87M
Seattle Genetics SGEN:US $ 478.08M 23.68M
Teva Pharmaceutical TEVA:IT 3.33B 220M
Xencor XNCR:US $ 58.36M 8.72M
YTE INCY:US $ 564.87M 58.95M